At a glance
- Originator Sanofi Winthrop
- Class Analgesics; Muscle relaxants
- Mechanism of Action Neurokinin antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pain
Most Recent Events
- 22 Dec 1995 Discontinued-Preclinical for Pain in USA (Unknown route)
- 02 Oct 1995 This profile is new.
- 02 Oct 1995 Preclinical development for Pain in USA (Unknown route)